RecruitingNot applicableNCT06068023

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

Studying Carcinoma of the ampulla of Vater

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione Poliambulanza Istituto Ospedaliero
Principal Investigator
Moh'd Abu Hilal, MD, PhD
Fondazione Poliambulanza Instituto Ospedaliero
Intervention
Folfirinox(drug)
Enrollment
400 enrolled
Eligibility
18-100 years · All sexes
Timeline
20232028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06068023 on ClinicalTrials.gov

Other trials for Carcinoma of the ampulla of Vater

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of the ampulla of Vater

← Back to all trials